GSK/ViiV Healthcare, in collaboration with Associate Prof. Dalibor Sedláček of the Pilsen University Hospital and Prof. José Gatell from Spain, has created an opportunity for the Czech professional public to meet and discuss current development, treatment and professional experience issues with world-renowned HIV experts at the occasion of the 6th annual World AIDS Day symposium, which will be held on 21–22 November in Pilsen.
GSK/ViiV Healthcare, in collaboration with Associate Prof. Dalibor Sedláček of the Pilsen University Hospital and Prof. José Gatell from Spain, has created an opportunity for the Czech professional public to meet and discuss current development, treatment and professional experience issues with world-renowned HIV experts at the occasion of the 6th annual World AIDS Day symposium, which will be held on 21–22 November in Pilsen.
The meeting builds on the EACS (European AIDS Clinical Society) Conference, the most important European event for over 3,000 HIV experts from around the world, which was held two weeks ago in Basel, Switzerland. The president of EACS is Prof. Jürgen Rockstroh from Germany, who will also participate in the Pilsen symposium, where he will be joined by other world-renowned experts – Prof. José Gatell from Spain, honorary professor at the University ofBarcelona, former president of EACS and the guarantor of the international expert symposium in Pilsen and Prof. Pavol Jarčuška from Slovakia, president of the Slovak Society of SLS Infectologists. Associate Prof. Dalibor Sedláček of the Pilsen University Hospital is in charge of organizing the 6th annual World AIDS Day, in conjunction with which the international symposium is being held.
“Czech HIV experts are among the European leaders in the field of HIV, and thus Czech HIV positive patients can potentially have a comparable quality and life expectancy to the healthy population too. A properly treated HIV patient may not even be infectious to his/her partner. Knowing the diagnosis in time is crucial,” says Prof. José Gatell, the guarantor of the international expert symposium organized by GSK/ViiV Healthcare.
“We are pleased to have the opportunity to support international discussion on current issues and the latest findings on the treatment of HIV, to which our company is a major contributor worldwide, through the symposium in Pilsen,” said Emmanuelle Boishardy, General Manager of GSK in the Czech Republic.
The last 30 years have changed society and changed also what we know and how we treat HIV.